WINCAP FINANCIAL LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2064588 BOSTON, MA

Position in GILD

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$739,468

-$57,589 QoQ

Shares Held

5,853

+2.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.75%

of 13F equity value

Holder Rank

#1,211

of 2,266 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WINCAP FINANCIAL LLC holds $8,253,715 across 6 Drug Manufacturers - General names. GILD ranks #6 (9.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	10,261	$2,582,078
2	MRK	Merck & Co., Inc.	12,130	$1,558,705
3	BMY	Bristol Myers Squibb Co	23,756	$1,368,820
4	PFE	Pfizer Inc	46,496	$1,119,623
5	AMGN	Amgen Inc	2,444	$885,021
6	GILD	Gilead Sciences, Inc. This page	5,853	$739,468

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$739,468	5,853	+2.3%	Shares	Sole	2026-07-09
2026-03-31	$797,057	5,719	+3.8%	Shares	Sole	2026-04-09
2025-12-31	$675,929	5,507	+1.8%	Shares	Sole	2026-01-14
2025-09-30	$600,288	5,408	+4.0%	Shares	Sole	2025-11-07
2025-06-30	$576,413	5,199	-17.2%	Shares	Sole	2025-08-01
2025-03-31	$703,898	6,282	—	Shares	Sole	2025-05-07
No filing history on record for this holder in this stock.